Any compound that potentiates this pathway carries a theoretical risk of promoting neoplastic processes (PMID: 34179015) No Chronic Toxicity Data: Long-term effects of sustained HGF/c-Met potentiation are unstudied even in animal models Uncharacterized Dose-Response: The relationship between Dihexa dose and adverse effects in any living system is poorly defined beyond acute preclinical studies No Regulatory Review: Dihexa has never undergone the systematic safety evaluation required for regulatory submission Safety Comparison Summary: Cerebrolysin has a known, well-characterized safety profile from decades of clinical use
Say goodbye to dull, tired skin and hello to a luminous, youthful glow
Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: In vitro ERK1/2 activation and role in Alzheimers disease
For companies engaged in compounding of GLP-1 drug products, the warnings signal a need to reassess labeling, advertising, and promotional strategies
Jin L, Kimura S, Zhou Y, Kuroda J, Asou H, Inaba T, Milda T, Konopleva M, Andreeff M , Tabe Y
Texture-wise, though, its lightweight, zero sticky residue, and does not pill under makeup
